Deep Learning-Based Culture-Free Bacteria Detection in Urine Using Large-Volume Microscopy

Rafael Iriya,Brandyn Braswell,Manni Mo,Fenni Zhang,Shelley E. Haydel,Shaopeng Wang
DOI: https://doi.org/10.3390/bios14020089
2024-02-06
Biosensors
Abstract:Bacterial infections, increasingly resistant to common antibiotics, pose a global health challenge. Traditional diagnostics often depend on slow cell culturing, leading to empirical treatments that accelerate antibiotic resistance. We present a novel large-volume microscopy (LVM) system for rapid, point-of-care bacterial detection. This system, using low magnification (1–2×), visualizes sufficient sample volumes, eliminating the need for culture-based enrichment. Employing deep neural networks, our model demonstrates superior accuracy in detecting uropathogenic Escherichia coli compared to traditional machine learning methods. Future endeavors will focus on enriching our datasets with mixed samples and a broader spectrum of uropathogens, aiming to extend the applicability of our model to clinical samples.
chemistry, analytical,nanoscience & nanotechnology,instruments & instrumentation
What problem does this paper attempt to address?
The paper attempts to address the limitations of traditional methods in diagnosing urinary tract infections (UTIs). Specifically, traditional diagnostic methods rely on slow cell culture processes, which lead to an increase in empirical treatments and subsequently accelerate the development of antibiotic resistance. Additionally, while urine dipstick tests are quick and cost-effective, their limited sensitivity may result in inaccurate outcomes. To address these issues, the paper proposes a deep learning-based large volume microscopy (LVM) system for culture-free bacterial detection. This system visualizes a sufficient sample volume through low magnification (1-2x) microscopy, eliminating the need for culture medium enrichment. Combined with deep neural networks, the model demonstrates higher accuracy in detecting uropathogenic Escherichia coli compared to traditional machine learning methods. Future work will focus on enriching the dataset, including mixed samples and a broader range of uropathogens, to expand the model's applicability to clinical samples.